News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News NICE rejects second Alexion ultra-rare disease drug NHS will not fund Kanuma for rare disease LAL-D.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Acacia ready to file its anti-vomiting treatment Potential launch in 2018 if FDA approves Baremsis.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News CDC panel votes to scrap hepatitis B birth dose advice CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
